Pune, India, June 16, 2021 (GLOBE NEWSWIRE) – The increasing prevalence of various types of cancer around the world molecular diagnostics market in oncology, Says Fortune Business Insights in a report titled “Global Oncology Molecular Diagnostics Market Size, Share and Trend by Product (Instruments, Reagents), by Cancer Type (Blood Cancer, Prostate Cancer, Colorectal Cancer, Cancer of skin, cervical cancer), by Technology (polymerase chain reaction, microarrays and microarrays, sequencing, mass spectroscopy, transcription amplification), by end user (hospitals, diagnostic centers) and forecast geographic areas until 2026.

The increasing move towards precision medicine is expected to enable the growth of the global oncology molecular diagnostics market.

Get a sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-molecular-diagnostics-market-101145

Growing demand for automated and advanced diagnostics will drive growth

The increasing prevalence of numerous cancers is likely to support the revenue growth of the global automated and advanced diagnostics market. The increasing move towards precision medicine and the increasing demand for preventive care are expected to drive the growth of the global molecular diagnostics in oncology market.

In addition, the growing demand for automated and advanced diagnostic techniques for cancer is also expected to contribute to the global molecular diagnostics in oncology market shares. According to the World Health Organization, the number of cancer cases worldwide in 2018 is estimated at 18.0 million, which is expected to further fuel the global oncology molecular diagnostics market.

Browse the full report:

https://www.fortunebusinessinsights.com/industry-reports/oncology-molecular-diagnostics-market-101145

Furthermore, favorable healthcare reimbursement policies are likely to favor the growth of the Global Molecular Oncology Diagnostics Market. In addition, acquisitions and mergers of key companies are expected to drive the growth of the global molecular diagnostics in oncology market during the forecast period. For example, cancer Genetics announced a merger with NovellusDx whereby Cancer Genetics’ portfolio of oncology tests and services will combine with next-generation sequencing and other technologies from NovellusDx. Likewise, Biodesix, Inc., announced the acquisition of Integrated Diagnostics, Inc., which resulted in the acquisition of the Company’s oncology product, the XL2 test.

In addition, the launch of MammaTyper is also expected to propel the growth of the global oncology molecular diagnostics market. For example, BioNTech SE launched MammaTyper, a molecular diagnostic test for breast cancer that was developed in collaboration with Stratifyer. However, the high costs associated with molecular diagnostics, budget limitations, and the requirement for sophisticated facilities are the major factors that are expected to hamper the growth of the global oncology molecular diagnostics industry.

Quick purchase Molecular diagnostics in oncology market

https://www.fortunebusinessinsights.com/checkout-page/101145

Rapid Adoption of Advanced Diagnostic Techniques Will Drive Growth in North America

Geographically, the global oncology molecular diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America is expected to dominate the global oncology molecular diagnostics market during the forecast period owing to the rapid adoption of advanced diagnostic techniques and sedentary lifestyles.

According to the American Cancer Society (ACS), melanoma or skin cancer is the most common type of cancer in the United States and is estimated to number around 91,270 people. Favorable healthcare reimbursement policies will further increase growth in the region. In Asia-Pacific, the molecular oncology diagnostics market is expected to grow at a significant rate owing to the growth of the geriatric population and the increasing research into precision drugs. High unmet cancer needs are also expected to fuel growth in Asia-Pacific.

Talk to the analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-molecular-diagnostics-market-101145

Main leading players mentioned:

  • Abbott
  • Becton
  • Dickinson and company
  • F. Hoffmann-La Roche Ltée
  • Cepheid
  • Bayer AG
  • Agilent Technologies
  • Danaher
  • Hologically
  • Sysmex Company
  • Siemens Health GmbH.

Take a look at the related reports:

Urinary Incontinence Devices Market Size, share and global trend by product (urethral inserts, pessary, slings for men, slings for women, artificial urinary sphincters, electrical stimulation devices), by type (stress incontinence, urge incontinence, overflow incontinence, mixed incontinence ), by patient (male and female), by end user (clinics, hospitals, outpatient surgery centers, home care facilities) and geographic forecasts until 2021-2028

Point of Care Veterinary Diagnostics Market Global Size, Share and Trend by Types (Kit, Instruments), Application (Hormone Level Testing, Infectious Disease Testing), End Users (Veterinary Hospitals, Home Care Facilities, Veterinary Clinics) and Geographic Forecast to 2021- 2028

Disposable Contact Lenses Market Size, share and global trend by type (cylindrical lenses, toric lenses, spherical lenses), by distribution channel (optical stores, online stores), by material (silicon, hydrogel, polymers, hydrogel), by use (lenses correctors, therapeutic lenses), Cosmetics) and Geography Forecast until 2021-2028

Eye Supplements Market Global size, share and trend by product type (antioxidants, fatty acids, anti-inflammatory supplements, neuroprotective supplements), by form (liquid, gels, capsule, tablet), by application (eye health, muscle degeneration, diabetic retinopathy , Cataract, Glaucoma), by distribution channel (hospital pharmacy, retail pharmacy, online pharmacy) and geographic forecast until 2021-2028

About Us:

Fortune Business Insights ™ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions to our clients, helping them meet the specific challenges of their businesses. Our aim is to provide our clients with comprehensive market information, giving them a granular overview of the market in which they operate.

Our reports contain a unique blend of tangible information and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use cutting-edge research tools and techniques to compile comprehensive market research, interspersed with relevant data.

At Fortune Business Insights ™, we aim to highlight the most lucrative growth opportunities for our clients. We therefore offer recommendations allowing them to navigate more easily in technological and market-related developments. Our consulting services are designed to help organizations identify hidden opportunities and understand dominant competitive challenges.

Contact us:

Fortune Business Insights ™ Pvt. Ltd.

308, Supreme Headquarters,

Investigation n ° 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Call:

United States: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

E-mail:[email protected]

LinkedIn | Twitter | Blogs





Source link

Leave a Reply

Your email address will not be published.